CHESAPEAKE ASSET MANAGEMENT LLC

Position in ABBV — AbbVie Inc.

CIK 1079397 NEW YORK, NY

Position in ABBV

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$1,450,201

+$220,078 QoQ

Shares Held

5,763

+1.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.05%

of 13F equity value

Holder Rank

#2,205

of 4,150 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHESAPEAKE ASSET MANAGEMENT LLC holds $16,421,292 across 10 Drug Manufacturers - General names. ABBV ranks #3 (8.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	9,659	$11,585,295
2	MRK	Merck & Co., Inc.	15,999	$2,055,871
3	ABBV	AbbVie Inc. This page	5,763	$1,450,201
4	JNJ	Johnson & Johnson	4,549	$1,155,309
5	PFE	Pfizer Inc	4,008	$96,512
6	BMY	Bristol Myers Squibb Co	972	$56,006
7	GSK	GSK plc	248	$13,000
8	AZN	Astrazeneca PLC	37	$7,015

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,450,201	5,763	+1.9%	Shares	Sole	2026-08-04
2026-03-31	$1,230,123	5,656	-13.9%	Shares	Sole	2026-05-12
2025-12-31	$1,500,493	6,567	+0.1%	Shares	Sole	2026-01-08
2025-09-30	$1,519,133	6,561	-1.6%	Shares	Sole	2025-10-17
2025-06-30	$1,237,157	6,665	0.0%	Shares	Sole	2025-10-15
2025-03-31	$1,396,450	6,665	+3.9%	Shares	Sole	2026-01-05
2024-12-31	$1,140,123	6,416	-0.8%	Shares	Sole	2026-01-05
2024-09-30	$1,277,695	6,470	+1.5%	Shares	Sole	2026-01-05
2024-06-30	$1,092,925	6,372	-3.1%	Shares	Sole	2026-01-05
2024-03-31	$1,196,943	6,573	-49.5%	Shares	Sole	2026-01-05
2023-12-31	$2,016,004	13,009	-4.0%	Shares	Sole	2026-01-05
2023-09-30	$2,019,912	13,551	+20.7%	Shares	Sole	2026-01-05
2023-06-30	$1,513,017	11,230	+15.2%	Shares	Sole	2026-01-05
2023-03-31	$1,554,176	9,752	—	Shares	Sole	2026-01-05
No filing history on record for this holder in this stock.